A Carbapenem-resistant Acinetobacter baumannii outbreak in the COVID intensive care unit of a community hospital was contained using multidrug resistant organism guidelines. The purpose of this study is to report on an outbreak investigation and containment strategy that was used, and to discuss prevention strategy.
This article describes nontuberculous mycobacteria (NTM) infections during 2012–2020 associated with health care and aesthetic procedures in France. Epidemiologic data was obtained from the national early warning response system for healthcare-associated infections and data on NTM isolates from the National Reference Center for Mycobacteria. Clinical and environmental isolates were compared by using whole-genome sequencing.
The Centers for Disease Control and Prevention awarded $85 million to health care–associated infection and antibiotic resistance (HAI/AR) programs in March 2015 as part of Infection Control Assessment and Response (ICAR) activities in the Epidemiology and Laboratory Capacity cooperative agreement Domestic Ebola Supplement. One goal of this funding was to assess and improve program capacity to respond to potential health care outbreaks (eg, HAI clusters). All 55 funded programs (in 49 state and 6 local health departments) participated.
Together, the Evelyn and Thomas McKnight Family Fund for Patient Safety and the CDC Foundation created The McKnight Prize for Healthcare Outbreak Heroes to encourage and reward those who serve and protect patients from harm related to healthcare outbreaks. Nominations for this year’s prize are now being accepted through Monday, February 28th, 2022. Candidates for the McKnight Heroes Prize can be from a variety of professions including, but not limited to, nurses, physicians, public health professionals, administrators, and patient advocates. The prize criteria focus on a candidate’s contributions to enhancing the response to a healthcare outbreak.
This article identifies and describes components of existent governmental reporting systems of NO aiming to inform the design of the implementation of NO reporting systems in countries where they were not fully established. Overall, the article highlights the need to explore and fill the gaps of outbreak management and response worldwide, in particular related to low- and middle-income countries.
This article discusses COVID-19 dedicated units that were created early in the pandemic. Despite their need, factors specific to these units can possibly increase the risk of bacterial cross-contamination between COVID-19 patients. We report a Serratia marcescens outbreak in a COVID-19 intensive care unit, later discussing factors specific to COVID-19 units that may facilitate bacterial cross-contamination in such units, and raising awareness for such an issue.
This article discusses how in the US, outpatient visits have climbed steadily, to nearly a million in 2019 alone. According to the CDC’s “Guide to Infection Prevention for Outpatient Settings: Minimum Expectations for Safe Care,” the past several decades have seen a “significant shift” in health care delivery from the acute, inpatient hospital setting to a variety of outpatient and community-based settings. More than three-fourths of all operations in the US are performed in settings outside the hospital.
The COVID-19 pandemic has affected infection prevention and control (IPC) programs worldwide. In this article, the impact of COVID-19 was evaluated on the University of Iowa Hospitals & Clinics IPC program by measuring the volume of calls to the program, changes in healthcare-associated infection rates, and team member perceptions.
Reports of organisms harboring multiple carbapenemase genes have increased since 2010. During October 2012–April 2019, the Centers for Disease Control and Prevention documented 151 of these isolates from 100 patients in the United States. Possible risk factors included recent history of international travel, international inpatient healthcare, and solid organ or bone marrow transplantation.
This study highlights the risk of nosocomial infection of SARS-CoV-2 from patients who become infectious midway into their hospitalization. The findings also reinforce the importance of patient contact time and aerosol-generating procedures as key risk factors for HCP infection with SARS-CoV-2.